Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

AstraZeneca to discontinue trial for heart disease drug Epanova

January 13, 2020 Sales and Marketing AstraZeneca, Phase II Trial, Phase III trial, heart disease, triglycerides

AstraZeneca expects a $100 million writedown for its heart disease drug Epanova, as it discontinues its late stage trial. This …
News

Sanofi secures expanded European approval for Toujeo in type 1 diabetes

January 10, 2020 Medical Communications, Sales and Marketing EU, Sanofi, pharma, toujeo

Sanofi has revealed that the European Commission has expanded the existing label for Toujeo (insulin glargine 300 units/mL) to include …
News

US approval for Blueprint Medicines’ gastrointestinal stromal tumour therapy

January 10, 2020 Medical Communications, Sales and Marketing Ayvakit, Blueprint Medicines, Cancer, pharma

The FDA has moved to authorise Blueprint Medicines’ kinase inhibitor Ayvakit (avapritinib) for the treatment of unresectable or metastatic gastrointestinal …
News
4420456374_64a3d7e6aa_88

Top Ten most popular articles on Pharmafile.com this week

January 10, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The US pharamaceutical industry dominates the news this week, with Pfizer, Sanofi and GlaxoSmithKline all increasing their drug prices while …
News
merck-keytruda

MSD’s Keytruda chalks up bladder cancer approval in the US

January 9, 2020 Sales and Marketing Cancer, MSD, bladder cancer, keytruda, pharma

MSD’s blockbuster immunotherapy Keytruda (pembrolizumab) has added another US approval to its repertoire with the news that FDA has awarded …
News
nmpa_logo

China approves first homegrown HPV vaccine

January 8, 2020 Research and Development, Sales and Marketing China, HPV, NMPA, pharma, vaccines

Female patients in China between the ages of nine and 45 will have access to the country’s first domestically-produced vaccine …
News
rami-levin-picture-3-002

Saniona appoints Rami Levin as President and Chief Executive Officer

January 8, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointments, rare diseases

Saniona has announced that Rami Levin will take over as the Chief Executive Officer of the company as it seeks …
Appointment
enrique_conterno

FibroGen names Lilly veteran as new CEO

January 7, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, fibrogen, pharma

Eli Lilly veteran Enrique Conterno has been revealed as the new Chief Executive Officer of FibroGen following the unexpected death …
Appointment
teva_copy

Teva to settle bribery lawsuit with $54 million payout

January 7, 2020 Manufacturing and Production, Sales and Marketing Teva, bribery, pharma

Israeli drug firm Teva has agreed to settle an ongoing lawsuit levying allegations of the company’s bribery of doctors, it …
News
ipsen-logo-big

MHRA expands approval of Dysport for symptomatic treatment of focal spasticity of the upper limbs in paediatric cerebral palsy

January 6, 2020 Sales and Marketing Dysport, MHRA, ipsen, pharma

Ipsen has secured an expansion in the UK to the existing label for Dysport (lemborexant), with the Medicines and Healthcare …
News
5204602349_c87b204860_b

FDA gives a priority review for key heart failure drug Farxiga

January 6, 2020 Sales and Marketing AstraZeneca, Heart Failures, farxiga

The FDA has accepted a New Drug Application (sNDA) and has granted a priority review for AstraZeneca’s drug Farxiga (dapagliflozin) …
News
smog_descends_on_wuhan_hubei_china

Mysterious viral pneumonia infects dozens in central China, bird flu and SARS ruled out

January 6, 2020 Sales and Marketing Bird Flu, China, Sars, WHO, World Health Organisation, Wuhan, pneumonia

A total of 59 cases of viral pneumonia have been reported in the city of Wuhan, with seven people in …
News
stock-incyte-01-shutter

Incyte’s drug stumbles at Phase 3 in treatment-naive acute graft-versus-host disease

January 6, 2020 Research and Development, Sales and Marketing Incyte, pharma, trial failure

Drugmaker Incyte has made it known that its selective JAK1 inhibitor therapy itacitinib fell short at Phase 3 in the …
News

AstraZeneca’s drug Lokelma approved in China

January 6, 2020 Sales and Marketing AstraZeneca, China, FDA, eu commission, kidney failure, potassium

AstraZeneca’s Lokelma has been approved by the National Medical Products Administration in China. This is due to positive results based …
News
janssen_latest_logo_on_sign

European Commission authorises Janssen’s anti-depressant Spravato

December 23, 2019 Sales and Marketing Janssen, MDD, Nasal Spray, TRD, depression, mental health

The European Commission has approved Janssen’s nasal spray Spravato (esketamine), which is used to treat major depressive disorder (MDD) that …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025